PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Vitamin D: Current Guidelines and Future Outlook.

Abstract Vitamin D is of public health interest because its deficiency is common and is associated with musculoskeletal diseases, as well as extraskeletal diseases, such as cancer, cardiovascular diseases, and infections. Several health authorities have reviewed the existing literature and published nutritional vitamin D guidelines for the general population. There was a wide consensus that serum 25-hydroxyvitamin D [25(OH)D] concentration should be used to assess vitamin D status and intake, and that musculoskeletal, and not extraskeletal, effects of vitamin D should be the basis for nutritional vitamin D guidelines. Recommended target levels for 25(OH)D range from 25 to 50 nmol/l (10 to 20 ng/ml), corresponding to a vitamin D intake of 400 to 800 International Units (10 to 20 μg) per day. It is of concern that significant sections of the general population do not meet these recommended vitamin D levels. This definitely requires action from a public health perspective.
PMID
Related Publications

Vitamin D status correction in Saudi Arabia: an experts' consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO).

Beneficial Effects of UV-Radiation: Vitamin D and beyond.

Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels--an observational study during clinical practice conditions.

Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency.

Clinical utility of vitamin d testing: an evidence-based analysis.

Authors

Mayor MeshTerms
Keywords

25(OH)D

Vitamin D

epidemiology

guidelines

review

supplementation

Journal Title anticancer research
Publication Year Start




PMID- 29374751
OWN - NLM
STAT- In-Process
LR  - 20180201
IS  - 1791-7530 (Electronic)
IS  - 0250-7005 (Linking)
VI  - 38
IP  - 2
DP  - 2018 Feb
TI  - Vitamin D: Current Guidelines and Future Outlook.
PG  - 1145-1151
AB  - Vitamin D is of public health interest because its deficiency is common and is
      associated with musculoskeletal diseases, as well as extraskeletal diseases, such
      as cancer, cardiovascular diseases, and infections. Several health authorities
      have reviewed the existing literature and published nutritional vitamin D
      guidelines for the general population. There was a wide consensus that serum
      25-hydroxyvitamin D [25(OH)D] concentration should be used to assess vitamin D
      status and intake, and that musculoskeletal, and not extraskeletal, effects of
      vitamin D should be the basis for nutritional vitamin D guidelines. Recommended
      target levels for 25(OH)D range from 25 to 50 nmol/l (10 to 20 ng/ml),
      corresponding to a vitamin D intake of 400 to 800 International Units (10 to 20
      mug) per day. It is of concern that significant sections of the general
      population do not meet these recommended vitamin D levels. This definitely
      requires action from a public health perspective.
CI  - Copyright(c) 2018, International Institute of Anticancer Research (Dr. George J. 
      Delinasios), All rights reserved.
FAU - Pilz, Stefan
AU  - Pilz S
AD  - Division of Endocrinology and Diabetology, Department of Internal Medicine,
      Medical University of Graz, Graz, Austria [email protected]
FAU - Trummer, Christian
AU  - Trummer C
AD  - Division of Endocrinology and Diabetology, Department of Internal Medicine,
      Medical University of Graz, Graz, Austria.
FAU - Pandis, Marlene
AU  - Pandis M
AD  - Division of Endocrinology and Diabetology, Department of Internal Medicine,
      Medical University of Graz, Graz, Austria.
FAU - Schwetz, Verena
AU  - Schwetz V
AD  - Division of Endocrinology and Diabetology, Department of Internal Medicine,
      Medical University of Graz, Graz, Austria.
FAU - Aberer, Felix
AU  - Aberer F
AD  - Division of Endocrinology and Diabetology, Department of Internal Medicine,
      Medical University of Graz, Graz, Austria.
FAU - Grubler, Martin
AU  - Grubler M
AD  - Division of Endocrinology and Diabetology, Department of Internal Medicine,
      Medical University of Graz, Graz, Austria.
AD  - Swiss Cardiovascular Center Bern, Department of Cardiology, Bern University
      Hospital, Bern, Switzerland.
FAU - Verheyen, Nicolas
AU  - Verheyen N
AD  - Department of Cardiology, Medical University of Graz, Graz, Austria.
FAU - Tomaschitz, Andreas
AU  - Tomaschitz A
AD  - Specialist Clinic of Rehabilitation Bad Gleichenberg, Bad Gleichenberg, Austria.
AD  - Medical Clinic V (Nephrology, Hypertensiology, Endocrinology, Diabetology,
      Rheumatology), Mannheim Medical Faculty, University of Heidelberg, Mannheim,
      Germany.
FAU - Marz, Winfried
AU  - Marz W
AD  - Medical Clinic V (Nephrology, Hypertensiology, Endocrinology, Diabetology,
      Rheumatology), Mannheim Medical Faculty, University of Heidelberg, Mannheim,
      Germany.
AD  - Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical
      University of Graz, Graz, Austria.
AD  - Synlab Academy, Synlab Laboratory Services GmbH, Mannheim, Germany.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Greece
TA  - Anticancer Res
JT  - Anticancer research
JID - 8102988
OTO - NOTNLM
OT  - *25(OH)D
OT  - *Vitamin D
OT  - *epidemiology
OT  - *guidelines
OT  - *review
OT  - *supplementation
EDAT- 2018/01/29 06:00
MHDA- 2018/01/29 06:00
CRDT- 2018/01/29 06:00
PHST- 2017/10/30 00:00 [received]
PHST- 2017/12/05 00:00 [revised]
PHST- 2017/12/06 00:00 [accepted]
PHST- 2018/01/29 06:00 [entrez]
PHST- 2018/01/29 06:00 [pubmed]
PHST- 2018/01/29 06:00 [medline]
AID - 38/2/1145 [pii]
AID - 10.21873/anticanres.12333 [doi]
PST - ppublish
SO  - Anticancer Res. 2018 Feb;38(2):1145-1151. doi: 10.21873/anticanres.12333.